Sign In
Buy ICU
$3.12
+0.140 (+4.70%)
At Close: Jun 26, 2026
SeaStar Medical Announces New ICD-10-PCS Codes for Its SCD Therapy for Acute Kidney Injury
08:25am, Tuesday, 23'rd Jun 2026
Enables standardized inpatient hospital billing for QUELIMMUNE ® (SCD-PED) therapy
SeaStar Medical to Present at Upcoming Investor Summit Conference
08:45am, Monday, 22'nd Jun 2026
DENVER, June 22, 2026 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq: ICU), a commercial-stage healthcare company focused on transformational treatments for critically ill patients fa
This ICU Medical Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday
09:15am, Monday, 15'th Jun 2026
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings pag
2,447 shares sold for a transaction value of ~$304,000. This sale represented 11.17% of Sanzone's direct holdings.
SeaStar Medical Holding Corporation (ICU) Q1 2026 Earnings Call Transcript
06:50pm, Wednesday, 13'th May 2026
SeaStar Medical Holding Corporation (ICU) Q1 2026 Earnings Call Transcript
SeaStar Medical Reports First Quarter Financial Results and Provides Business Updates
04:05pm, Wednesday, 13'th May 2026
Added 7 top-rated children's hospitals to QUELIMMUNE ® pediatric acute kidney injury (AKI) customer base, increasing first quarter revenue 69% versus first quarter 2025 revenue Advanced enrollment in
Implied Volatility Surging for ICU Medical Stock Options
09:50am, Friday, 08'th May 2026
Investors need to pay close attention to ICUI stock based on the movements in the options market lately.
ICU Medical Announces First Quarter 2026 Results
04:05pm, Thursday, 07'th May 2026
SAN CLEMENTE, Calif., May 07, 2026 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced financial resu
SeaStar Medical to Report First Quarter Financial Results on May 13, 2026
08:20am, Wednesday, 06'th May 2026
DENVER, May 06, 2026 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq: ICU), a commercial-stage healthcare company focused on transforming treatments for critically ill patients facing
ICU Medical Announces Time of First Quarter 2026 Earnings Conference Call
08:30am, Thursday, 23'rd Apr 2026
SAN CLEMENTE, Calif., April 23, 2026 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq: ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced the time of
Ondine Biomedical shares rise 8% as ICU study shows nasal photodisinfection cuts pneumonia rates by nearly 40%
07:15am, Tuesday, 14'th Apr 2026
A peer-reviewed pilot study at a Canadian critical care centre marks the first deployment of nasal photodisinfection in an intensive care setting. Ondine Biomedical Inc (AIM:OBI, OTC:OBIMF) shares ros
ICU Medical Moving Toward A Cleaner Margin Leverage And Capital Return Story
04:32pm, Friday, 10'th Apr 2026
ICU Medical is positioned for margin expansion as Smiths Medical integration and remediation costs subside, with upcoming product launches supporting growth. ICUI is gaining share in infusion pumps an
Contrasting Auna (NYSE:AUNA) & SeaStar Medical (NASDAQ:ICU)
01:23am, Thursday, 02'nd Apr 2026
Auna (NYSE: AUNA - Get Free Report) and SeaStar Medical (NASDAQ: ICU - Get Free Report) are both small-cap medical companies, but which is the better investment? We will contrast the two companies bas
Results from pediatric patients in the SAVE Registry shows no device-related adverse events or immunosuppression and continued strong survival data
SeaStar Medical Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Updates
04:05pm, Wednesday, 25'th Mar 2026
Added top-rated children's hospitals to QUELIMMUNE™ pediatric Acute Kidney Injury (AKI) customer base Completed enrollment in FDA-mandated QUELIMMUNE SAVE Post-Marketing Registry Exceeded 50% enroll
